Illumina Inc (ILMN)
NASDAQ · Healthcare · Diagnostics & Research
Illumina Inc is a Healthcare company with a market capitalization of $26.71B and a trailing P/E ratio of 32.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $1.15 | $1.06 | +8.5% |
| Q4 2025 | February 5, 2026 | $1.35 | $1.23 | +9.8% |
| Q3 2025 | October 30, 2025 | $1.34 | $1.17 | +14.5% |
| Q2 2025 | July 31, 2025 | $1.19 | $1.01 | +17.8% |
| Q1 2025 | May 8, 2025 | $0.97 | $0.94 | +3.2% |
| Q4 2024 | February 6, 2025 | $0.86 | $0.92 | -6.5% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Illumina Inc's market cap?
As of June 29, 2026, Illumina Inc (ILMN) has a market capitalization of $26.71B.
What is Illumina Inc's P/E ratio?
Illumina Inc trades at a trailing price-to-earnings (P/E) ratio of 32.0. Its forward P/E is 33.8.
Does Illumina Inc pay a dividend?
Illumina Inc does not currently pay a dividend.
What sector is ILMN in?
Illumina Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Illumina Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Illumina Inc reported revenue of $4.34B and net income of $850.00M.
Ask your own questions about ILMN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.